Skip to content

Effect of Minimally Processed Animal Protein on Biomarkers for Cognitive Decline

Effect of Minimally Processed Animal Protein on Biomarkers for Cognitive Decline

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06261775
Enrollment
36
Registered
2024-02-15
Start date
2024-01-30
Completion date
2026-07-02
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Lifestyle

Brief summary

Minimally processed animal protein is a premier source of essential macro and micronutrients in the diet and is important, especially to older adults who are at increased risk of nutritional deficiency and age-related physiological changes. Our central hypothesis is that adding lean animal protein within a healthy diet following macronutrient recommendations for Americans will enhance nutrient adequacy and attenuate markers of cognitive decline. This is a retrospective study leveraging samples collected from the feeding trial NCT05581953. PI for both studies are the same.

Interventions

OTHERRed meat-based meal

Participants were provided with food as part of a meal plan. The research team provided all foods and snacks for the intervention.

OTHERNo meat diet

Participants were provided with food as part of a meal plan. The research team provided all foods and snacks for the intervention.

Sponsors

South Dakota State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Generally, good health status based on one routine physical in the past 15 months, current health status * Normal HbA1C, weigh 110 lb or more * Age 65 years or more, generally healthy, all races and both sexes * Generally practicing a meat-based dietary pattern, do not have any special dietary requirements, and * Willingness to comply with the study protocol, including on-site meal consumption and sample/data collection.

Exclusion criteria

* Medication usage, probiotic, long-term antibiotic, and tobacco/drug/alcohol use * Not on any special diet within 3 months of recruitment, and do not intend to lose weight * Impaired kidney functions * Active history of cancer, diabetes, heart, liver, and kidney diseases * Major gastrointestinal disorders in the past 3 months * History of heart attacks or stroke * Unable to meet in-person visit requirements for dining, picking up meals, and tests * Any mental health condition affecting the ability to provide written informed consent * If they had not had a routine health checkup 12 months before recruitment. * If they were unwilling to abstain from taking nutritional supplements, alcohol, non-study foods, and beverages during the study period.

Design outcomes

Primary

MeasureTime frameDescription
Concentration of phosphatidylcholine in blood8 weeksUsing Microplate Assay

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMoul Dey, Ph.D

South Dakota State University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026